by Indigo | Mar 1, 2024 | 2024, News
Indigo closed its SHINE clinical trial, marking a significant milestone in the development of innovative healthcare technology. The trial, designed to evaluate the longer-term stability of Indigo’s continuous multi-metabolite (‘CMM’) device, has concluded its phase...
by Indigo | Jan 31, 2024 | 2024, News
We’re absolutely thrilled to share some fantastic news with you all! Our CEO, Danaë Delbeke, has been recognized as one of the 100 Most Prominent Women in Belgian Media!This prestigious acknowledgment highlights her remarkable leadership, dedication, and...
by Indigo | Nov 30, 2023 | 2023, News
The Music4Diabetes consortium has unveiled an ambitious initiative aimed at revolutionizing Type 1 Diabetes treatment. The latest project involves the development of an implantable multi-metabolite sensor, seamlessly integrated with a continuous insulin delivery pump....
by Indigo | Oct 2, 2023 | 2023, News
Indigo’s CEO, Danaë Delbeke’s exclusive presentation on revolutionary continuous multi-metabolite monitoring (CMM®) sensor at the Life Science Intelligence Summit is now available for viewing! Catch up on the exciting insights shared by our CEO, Danaë Delbeke,...
by Indigo | Aug 1, 2023 | 2023, News
Indigo has secured its position among the top 10 most promising MedTech companies in the region. This recognition comes as Flanders continues to foster a vibrant ecosystem for startups, propelled by initiatives like Startup.Flanders. Supported by Flanders Investment...
by Indigo | Jun 19, 2023 | 2023, News
This year’s ADA (American Diabetes Association) conference in sunny San Diego (June 23-26, 2023) promises to be an exceptional event as industry leaders, Key Opinion Leaders, fellow researchers, and industry partners converge for collaboration and innovation!...